Białe ceramiczne naczynie sfotografowane z góry na ciemnym tle

The Fasting-Mimicking Diet (FMD): What Is It and What Does the Research Actually Show?

The fasting-mimicking diet (FMD) is a five-day nutrition protocol designed by Valter Longo's team that aims to trigger effects in the body similar to full fasting, while still providing a limited amount of food. It gained wide attention through the commercial product ProLon, but behind the marketing there's also a real, if still limited, body of scientific literature. We explain how FMD differs from water fasting, which populations it has actually been studied in, and where the evidence is stronger versus where it's still an early stage of research.

Redakcja VitMode — Badania i biomarkerythe VitMode editorial team, no individual bylinesPublishedSeptember 16, 202613 min readAbout 13 min left

How this article was made

Author: Redakcja VitMode — Badania i biomarkery — the VitMode editorial team, no individual bylines
Method: Prepared from primary sources: clinical trials, meta-analyses and guidelines. We describe study findings separately from our interpretation.
Source verification: Cited PubMed papers are automatically checked for a matching identifier, title and publication year.
Medical review: none — this article has not been reviewed by a physician
Last updated: September 16, 2026

The content is educational and does not replace medical advice. Read the full editorial process

Table of contents

TL;DR — key takeaways

→A fast where you're not actually hungry
→How FMD differs from full water fasting
→The first pilot study in humans
→What a randomized trial in type 2 diabetes shows
→Which populations FMD has actually been studied in
→Who FMD may not be right for
→ProLon versus doing FMD on your own
→Limitations of the available evidence
→Our editorial recommendation

A fast where you're not actually hungry

The fasting-mimicking diet (FMD) is a nutrition protocol developed by Prof. Valter Longo's team at the University of Southern California, typically lasting five days, in which a small amount of food is consumed — roughly 700-1100 kcal a day, low in protein and carbohydrates and high in unsaturated fats — instead of giving up food entirely. The idea is that this specifically composed, strictly limited meal plan tricks the body into "thinking" it's fasting and activates metabolic pathways similar to those seen in full water fasting, while reducing the risk and discomfort of complete food deprivation.

FMD gained widespread attention through the commercial product ProLon — a ready-made five-day meal kit developed by L-Nutra, a company co-founded by Longo himself. That's important context to keep in mind while reading research on the topic: a substantial portion of the scientific literature on FMD comes from Longo's lab or is funded by or linked to L-Nutra, which doesn't invalidate the results, but does call for factoring in the potential conflict of interest when interpreting them.

How FMD differs from full water fasting

Myth

If FMD is supposed to mimic fasting, the simplest and most effective approach is just water fasting — providing any food at all "ruins" the effect.

Fact

A study by Rangan et al. (2019, Cell Reports) directly compared FMD with water-only fasting in a mouse model of intestinal inflammation. The results showed that FMD — not water fasting alone — led to clear regeneration of the intestinal epithelium through stem cell activation, stronger control of the immune response, and an increase in beneficial gut bacteria (Lactobacillaceae, Bifidobacteriaceae). Water fasting alone increased regenerative markers and lowered some inflammatory markers, but did not reverse intestinal pathology as effectively as FMD did. In other words — in this specific research model, the limited nutrition during FMD didn't "ruin" the effect, it strengthened it.

This distinction has practical significance: FMD isn't a "gentler" version of water fasting created purely for convenience, but a separately designed protocol in which the specific composition and amount of food consumed is meant to be part of the mechanism of action, not just a concession to comfort. That doesn't mean FMD is automatically "better" than water fasting in every context — most comparative studies come from animal models, and there are still few direct head-to-head studies in humans.

The first pilot study in humans

What does the research say?

Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease

Wei M, Brandhorst S, Shelehchi M et al. (Valter Longo's team) · Science Translational Medicine · 2017

Study findings

The study included 100 generally healthy adults aged 18-70, randomly assigned to three months of an unrestricted diet or to three cycles of FMD (5 consecutive days per month for 3 months). Three FMD cycles reduced body weight, abdominal and total fat mass, lowered blood pressure, and reduced levels of insulin-like growth factor 1 (IGF-1) — a marker linked in animal studies to the rate of aging and cancer risk. No serious adverse effects were recorded. This was one of the first studies testing the safety and feasibility of the FMD protocol in humans, not a study evaluating hard endpoints such as mortality or the incidence of specific diseases.

Moderate evidenceView the study on PubMed

This describes what the study found. Editorial interpretation follows in the text below.

It's worth highlighting what this study actually shows and what it doesn't. It shows that short, repeated FMD cycles are mostly safe and feasible in healthy adults and affect measurable metabolic markers. It does not show that FMD extends lifespan in humans, prevents specific chronic diseases, or works better than other forms of calorie restriction — those questions would require much longer studies with hard endpoints, which are still lacking.

What a randomized trial in type 2 diabetes shows

What does the research say?

Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial

van den Burg EL, Schoonakker MP, van Peet PG, van den Akker-van Marle EM, Lamb HJ, Longo VD, Numans ME, Pijl H · Diabetologia · 2024

Study findings

A fully randomized, 12-month trial conducted in primary care in the Netherlands included 100 people with type 2 diabetes (BMI ≥27), assigned to monthly FMD cycles as an addition to standard care (n=51) or to standard care alone (n=49). Glycemic control improved in 53% of the FMD group versus 8% of the control group, remained stable in 23% versus 33%, and worsened in 23% versus 59%, respectively. The FMD program was also associated with reduced need for glucose-lowering medication in some participants. This is one of the first fully randomized FMD trials with a one-year follow-up in a real clinical population, rather than just in healthy volunteers.

Moderate evidenceView the study on PubMed

This describes what the study found. Editorial interpretation follows in the text below.

Which populations FMD has actually been studied in

What you can do

Populations covered by clinical trials on FMD

Healthy adults — the Wei et al. pilot study (2017), evaluating mainly safety and metabolic markers
People with type 2 diabetes — the Dutch randomized trial (2024) and smaller Asian studies assessing glycemic control
Breast cancer patients undergoing neoadjuvant chemotherapy — the DIRECT trial (multicenter, randomized, phase 2), where FMD was used as an addition to chemotherapy, assessing treatment tolerance and some side effects rather than FMD as a cancer therapy in its own right
Overweight and obese people with hypertension — smaller randomized trials comparing FMD cycles with a Mediterranean diet in terms of cardiometabolic risk
Critically ill patients in intensive care units — a pilot feasibility study (ICU-FM-1), at a very early, exploratory stage

Check your profile

Wondering if your diet covers everything you need?

Instead of guessing, check your wider profile. Answer a few questions about your diet, lifestyle, sun exposure, and goals.

Takes about 2 minutesBased on scientific evidence

Check your profile

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

Who FMD may not be right for

ProLon versus doing FMD on your own

The commercial ProLon kit is a ready-made set of precisely weighed meals for five days, designed to replicate the macronutrient ratios used in Longo's studies. Its advantages are convenience and consistency with the composition used in the research protocol; its downside is the price, usually significantly higher than the cost of self-prepared, comparable low-calorie, low-protein meals.

In theory, it's possible to replicate a similar protocol on your own — low calorie intake (roughly 700-1100 kcal a day), low protein, a high share of unsaturated fats and low-glycemic-index complex carbohydrates over 5 days. In practice, though, no clinical trial has directly tested homemade FMD equivalents against ProLon — so there's no direct evidence that a self-designed plan produces identical metabolic effects to the exact protocol that was studied. That's an important caveat when weighing the cost against the potential benefit.

Limitations of the available evidence

Despite a growing number of studies, the FMD literature has several notable limitations. First, a substantial portion of the research comes from the same research team (Longo and colleagues) or is linked to the commercial manufacturer ProLon, which doesn't disqualify the results but does call for more interpretive caution than with independently replicated studies. Second, most studies to date have relatively small sample sizes (a few dozen to a couple hundred participants) and assess intermediate markers (IGF-1, blood glucose, body weight) rather than hard endpoints such as long-term mortality or chronic disease incidence.

Third, the long-term safety of repeated, monthly FMD cycles used for years — rather than just over a study period of a few months to a year — remains poorly studied. Finally, effects observed in mouse studies (e.g., regeneration of intestinal stem cells) don't always translate directly to humans at the same scale, and some of the enthusiastic claims about FMD popular in the media go beyond what clinical studies in humans have actually shown.

Question	Short answer
How does FMD differ from water fasting?	FMD provides a limited amount of food with a specific composition — in a gut-model study it produced better regenerative effects than water fasting alone
Is FMD safe for healthy adults?	The pilot study (Wei et al. 2017) found no serious adverse effects across three cycles over three months
Does FMD help with type 2 diabetes?	A 2024 randomized trial showed improved glycemic control as an addition to standard care — not as a replacement for treatment
Do you have to buy ProLon?	There's no direct research comparing homemade equivalents with ProLon — convenience has a price, but it's not the only option
Does FMD treat cancer or slow aging in humans?	There's no hard clinical evidence for this — oncology studies assessed FMD as an addition to chemotherapy, not as a standalone therapy

The fasting-mimicking diet (FMD) at a glance

Our editorial recommendation

FMD is one of the few popular nutrition protocols actually backed by a growing body of clinical research, including at least one solid, fully randomized one-year trial in a real-world population. That sets it apart from many diet trends based mostly on anecdote. At the same time, a large share of that literature comes from a single research team linked to a commercial product, and studies with hard endpoints in humans remain scarce — which justifies cautious enthusiasm rather than uncritical acceptance of the marketing promises.

FMD is a rare case of a popular nutrition trend with real research backing — but 'real research backing' and 'proven longevity in humans' are still two different things, and it's worth telling them apart when reading headlines about this diet.

VitMode editorial team

Frequently asked questions

The key difference isn't just the low calorie intake, but the specific macronutrient ratios (low protein, high unsaturated fat) and the short, repeated time pattern (5 days a month, rather than continuous restriction). Research suggests it's this specific composition, not just the calorie deficit, that's meant to drive the observed metabolic effects, though there are few direct studies comparing FMD with a calorically equivalent but differently composed low-calorie diet.

No. A ketogenic diet is a long-term, continuously followed way of eating that's very low in carbohydrates. FMD is a short, few-day protocol with reduced calorie and protein intake, used cyclically rather than as a daily eating pattern.

Clinical trials have most often tested monthly cycles (once a month for 3-12 months). There's no solid research assessing the safety of more frequent use, and the decision about frequency is worth discussing with a doctor, especially with coexisting chronic conditions.

Clinical studies on FMD haven't focused in detail on combining it with intense training, and with such low calorie and protein intake, intense physical exertion can be harder to tolerate and potentially risky. A reasonable approach is to scale back training intensity during an FMD cycle and monitor your own tolerance.

Animal studies and indirect markers in humans (e.g., lower IGF-1) are consistent with the hypothesis of a potential effect on aging-related processes, but there are no direct, long-term clinical trials in humans assessing hard endpoints such as lifespan. This is an area of active research, not an established fact.

No. The 2024 Dutch trial showed that FMD as an addition to standard care improved glycemic control and reduced medication needs in some patients, but it was used under medical supervision as a supplement to therapy, not a replacement for it. Stopping diabetes medication on your own in favor of FMD without medical consultation is dangerous.

ProLon guarantees adherence to the exact ratios tested in the research and offers convenience, but it's notably more expensive than self-prepared meals with a similar calorie and macronutrient profile. There's no direct research comparing the two options, so the choice largely comes down to budget and convenience rather than a difference in proven effectiveness.

The most commonly reported effects in clinical studies are hunger, fatigue, headaches, and irritability during the cycle itself — similar to typical symptoms accompanying calorie restriction. The Wei et al. pilot study recorded no serious adverse effects across three cycles over three months in healthy adults, but safety data for years of regular use remain limited.

Sources (3)

Sources are numbered. PubMed items are automatically verified (identifier, title, year).

1Wei et al. 2017 — Science Translational MedicinePubMed
2van den Burg et al. 2024 — DiabetologiaPubMed
3Rangan et al. 2019 — Cell Reports (FMD vs. water fasting, mouse model)External source

Redakcja VitMode — Badania i biomarkery

VitMode editorial team — no individual bylines; content based on primary sources

VitMode Editorial — Lab Tests and Biomarkers is the VitMode editorial team responsible for: laboratory tests, interpreting results and ageing biomarkers. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.